In addition, it has been demonstrated that NDRG2 inhibits tumor cell proliferation and increases p53- or hypoxia-mediated apoptosis and its expression is correlated with patient survival and prognosis [4,8,9,28–30]. This evidence concerns the gene TP53 and neoplasm.